PAINWeek 2017 Archives - MPR

PAINWeek 2017

Efficacy of Abuse-Deterrent Morphine, Oxycodone Assessed

The researchers presented examined the effects of 66mg intact oral morphine ARER, 60mg crushed intranasal morphine ARER, 60mg crushed intranasal morphine ER, 30mg intact oral oxycodone ARIR, 30mg crushed intranasal oxycodone ARIR, and 30mg crushed intranasal IR oxycodone or placebo among nondependent recreational opioid users.